Term Name: diflomotecan
Synonyms: (5R)-5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-3H,15H-oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione, (5R)-5-ethyl-9,10-difluoro-5-hydroxy-1,4,5,13-tetrahydro-3H,15H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione, BN 80915, BN-80915, BN80915, diflomotecan, diflomotecanum
Definition: An organic heteropentacyclic compound that is (5R)-8-[(6,7-difluoroquinolin-3-yl)methyl]-5-ethyl-5-hydroxy-1,4,5,8-tetrahydrooxepino[3,4-c]pyridine-3,9-dione in which position 7 of the oxepinopyridine moiety is joined to position 3 of the difluoroquinoine ring by a single bond. An E-ring modified camptothecin analogue that has greater lactone stability in plasma compared with other topoisomerase I inhibitors.
Ontology: ChEBI [CHEBI:144046]  ( EBI )

Relationships
is a type of: epsilon-lactone organic heteropentacyclic compound organofluorine compound organonitrogen heterocyclic compound tertiary alcohol
has_functional_parent: (R)-homocamptothecin
has_role: antineoplastic agent EC 5.99.1.2 (DNA topoisomerase) inhibitor